PGC-1a rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function

Taiji Tsunemi, Travis D. Ashe, Bradley E. Morrison, Kathryn R. Soriano, Jonathan Au, Ruben A.Vázquez Roque, Eduardo R. Lazarowski, Vincent A. Damian, Eliezer Masliah, Albert R. La Spada*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

269 Scopus citations

Abstract

Huntington's disease (HD) is caused by CAG repeat expansions in the huntingtin (htt) gene, yielding proteins containing polyglutamine repeats that become misfolded and resist degradation. Previous studies demonstrated that mutant htt interferes with transcriptional programs coordinated by the peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC-1α), a regulator of mitochondrial biogenesis and oxidative stress. We tested whether restoration of PGC-1α could ameliorate the symptoms of HD in a mouse model. We found that PGC-1α induction virtually eliminated htt protein aggregation and ameliorated HD neurodegeneration in part by attenuating oxidative stress. PGC-1α promoted htt turnover and the elimination of protein aggregates by activating transcription factor EB (TFEB), a master regulator of the autophagy-lysosome pathway. TFEB alone was capable of reducing htt aggregation and neurotoxicity, placing PGC-1α upstream of TFEB and identifying these two molecules as important therapeutic targets in HD and potentially other neurodegenerative disorders caused by protein misfolding.

Original languageEnglish (US)
Article number142ra97
JournalScience translational medicine
Volume4
Issue number142
DOIs
StatePublished - Jul 11 2012

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'PGC-1a rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function'. Together they form a unique fingerprint.

Cite this